Current status:
Cancelled Post Market
Current status date:
2008-08-05
DIN:
00147656
Electronic product monograph is not available
Company:
NEOLAB INC
31 B
665 Millway Avenue
Concord
Ontario
Canada
L4K 3T8
Route(s) of administration:
Oral
Number of active ingredient(s):
4
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS):
See footnote 3
48:16.00
,
48:08.00
Anatomical Therapeutic Chemical (ATC):
See footnote 4
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
CODEINE PHOSPHATE
|
65 MG / 30 ML
|
IPECAC
|
1 ML / 30 ML
|
POTASSIUM CITRATE
|
975 MG / 30 ML
|
SQUILL
|
1.5 ML / 30 ML
|